Citigroup
ACER

Citigroup’s Acer Therapeutics Inc ACER Stock Holding History

Citigroup’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,000
Closed -$3K – 6425
2021
Q2 		$3K Sell
1,000
-285
-22% -$820 ﹤0.01% 5946
2021
Q1 		$4K Buy
1,285
+1,000
+351% +$3.4K ﹤0.01% 5967
2020
Q4 		$1K Sell
285
-2
-0.7% -$5 ﹤0.01% 7309
2020
Q3 		$1K Sell
287
-75
-21% -$242 ﹤0.01% 7405
2020
Q2 		$1K Sell
362
-1,472
-80% -$4.16K ﹤0.01% 7489
2020
Q1 		$4K Buy
1,834
+471
+35% +$1.73K ﹤0.01% 7338
2019
Q4 		$5K Buy
1,363
+473
+53% +$1.61K ﹤0.01% 7414
2019
Q3 		$2K Sell
890
-515
-37% -$1.51K ﹤0.01% 7564
2019
Q2 		$5K Sell
1,405
-7,708
-85% -$147K ﹤0.01% 7491
2019
Q1 		$221K Buy
+9,113
New +$215K ﹤0.01% 4997
2018
Q3 		– Sell
-3
Closed – – 7909
2018
Q2 		$0 Hold
3
– – ﹤0.01% 7783
2018
Q1 		$0 Hold
3
– – ﹤0.01% 7716
2017
Q4 		$0 Hold
3
– – ﹤0.01% 7687
2017
Q3 		$0 Buy
+3
New +$29 ﹤0.01% 7504
2016
Q2 		– Sell
-31
Closed -$1K – 7531
2016
Q1 		$1K Buy
+31
New +$679 ﹤0.01% 7357
2015
Q4 		– Sell
-295
Closed -$10K – 7943
2015
Q3 		$10K Buy
295
+280
+1,867% +$9.87K ﹤0.01% 6441
2015
Q2 		$1K Buy
+15
New +$576 ﹤0.01% 7364
2015
Q1 		– Sell
-13
Closed -$1K – 7500
2014
Q4 		$1K Buy
13
+2
+18% +$145 ﹤0.01% 7009
2014
Q3 		$1K Buy
+11
New +$1.31K ﹤0.01% 6953
2014
Q1 		– Sell
-1
Closed – – 7249
2013
Q4 		$0 Sell
1
-26
-96% -$4.23K ﹤0.01% 7195
2013
Q3 		$5K Buy
+27
New +$3.61K ﹤0.01% 6422

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Citigroup's ACER Position: Q3 2021 in Review

Citigroup sold out of Acer Therapeutics Inc (ACER) in Q3 2021, closing a stake of 1,000 shares — an estimated $3K sold.

Citigroup first reported a position in ACER in Q3 2013 and held it in 21 quarters. The position peaked at $221K in Q1 2019. 25 funds tracked by Wall St. Rank hold ACER as of Q3 2021.

  • Citigroup reported no remaining Acer Therapeutics Inc position as of Q3 2021 after selling out during the quarter.
  • Citigroup sold 1,000 Acer Therapeutics Inc shares in Q3 2021, an estimated $3K.
  • Citigroup first reported a position in Acer Therapeutics Inc in Q3 2013 and held it in 21 quarters.
  • Citigroup's Acer Therapeutics Inc position peaked at $221K in Q1 2019.
  • 25 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2021.

Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.